Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells

Among the genotoxic drug regimens, doxorubicin (DOX) is known for its high-dose side effects in several carcinomas, including cervical cancer. This study reports on testing the combined use of a DOX genotoxic drug and SCR-7 non-homologous end joining (NHEJ) inhibitor for HeLa cells. An in vitro DNA...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Cancer Prev
Main Authors: Kumar, Ajay, Bhatkar, Devyani, Jahagirdar, Devashree, Sharma, Nilesh Kumar
格式: Artigo
語言:Inglês
出版: Korean Society of Cancer Prevention 2017
主題:
Short Communication
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5380189/
https://ncbi.nlm.nih.gov/pubmed/28382286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15430/JCP.2017.22.1.47
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍